New biopsy technique aims to predict prostate cancer's next move
NCT ID NCT02313623
First seen Feb 16, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tested whether combining MRI and ultrasound imaging with single-cell analysis of biopsy samples can better predict how prostate cancer will progress. Researchers enrolled 600 men scheduled for a special targeted biopsy. The goal was to see if they could grow prostate cancer cells in the lab and use their unique protein and genetic profiles to improve treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale University
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.